Meeting
2017 ASCO Annual Meeting
Development of a pan-cancer 15 gene expression signature to detect a subgroup driven by EMT/MAPK signalling.
Authors
Nuala McCabe
Almac Diagnostics, Craigavon, United Kingdom
Nuala McCabe , Laura A Knight , Bethanie Price , Andrena McCavigan , Aya El-Helali , Denis P Harkin , Charlie Gourley , Richard D. Kennedy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Tumor-Based Biomarkers
Citation
J Clin Oncol 35, 2017 (suppl; abstr 11616)
DOI
10.1200/JCO.2017.35.15_suppl.11616
Abstract #
11616
Poster Bd #
316
Abstract Disclosures
Similar Posters
First Author: Nuala McCabe
Poster
2024 ASCO Annual Meeting
PAS-004: A novel macrocyclic MEK inhibitor to inhibit cancer cell growth in vitro and tumor growth in mouse xenograft studies.
First Author: Graeme Currie
Poster
2020 ASCO Virtual Scientific Program
Phase I study of afatinib plus selumetinib in patients with KRAS mutation-positive colorectal, non-small cell lung and pancreatic cancer.
First Author: Sanne Huijberts
Poster
2024 ASCO Genitourinary Cancers Symposium
MAPK pathway alterations as a targetable vulnerability in bladder cancer.
First Author: Vincent D'Andrea